drugset / Trial / NCT00545259

Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation

NCT00545259

Phase 1 Completed 13 enrolled Novartis
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The study will evaluate the pharmacokinetic profile of AEB071 in the immediate post-transplant period in patients who have undergone their first liver transplant.

Timeline

Start
2007-10
Primary completion
2009-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject sotrastaurin Small molecule

Indications

No indication recorded.